FCER1A and neoplasm: A quantitative measure of the putative anti-tumor macrophage signature based on transcript levels of 3 factors extracted from the TCGA dataset, CD68, CD86 and FCERIA, further showed that the higher expression of this signature (named as FceM1) was correlated with the better survival of SKCM patients (Fig. 5f).